What is Pfizer's operating cash flow?

Pfizer (PFE) reported operating cash flow of $2.62B in Q1 2026.

How has Pfizer's operating cash flow changed year-over-year?

Pfizer's operating cash flow increased by 12.0% year-over-year, from $2.34B to $2.62B.

What is the long-term trend for Pfizer's operating cash flow?

Over 3 years (2021 to 2025), Pfizer's operating cash flow has grown at a -27.8% compound annual growth rate (CAGR), from $32.58B to $12.29B.

What does operating cash flow mean?

Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Pfizer PFE Operating Cash Flow

Operating Cash Flow at other companies

Bristol-Myers SquibbBMY

$1.1B-43.5%

Eli LillyLLY

$5.33B+220%

Johnson & JohnsonJNJ

$2.51B-39.8%

Merck & Co.MRK

$3.92B+56.7%

AmgenAMGN

$2.19B+57.4%

Ionis PharmaceuticalsIONS

-$792.82M-426%

Other financials

Income statement

See full

Revenue$14.5B+5.4%

Gross profit$10.9B+0.3%

Net income$2.7B-9.4%

EPS (diluted)$0.47-9.6%

Balance sheet

See full

Cash & equivalents$1.8B+18.8%

Total debt$64.4B+4.9%

Total equity$90.1B-0.3%

Total assets$207.62B-0.2%

Cash flow

See full

CapEx$436.0M-22.7%

Free cash flow$2.2B+23.0%

Valuation

See full

Market cap$134.91B-1.0%

Enterprise value$197.57B+0.7%

P/E11.1×—

P/S2.1×-0.1×

Profitability

See full

Gross margin73.5%+1.2pp

Net margin15.7%—

FCF margin18%+8.8pp

Returns & leverage

See full

Return on equity10.6%—

Debt / equity0.7×0.0×

Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pfizer's operating cash flow?: Pfizer (PFE) reported operating cash flow of $2.62B in Q1 2026.
How has Pfizer's operating cash flow changed year-over-year?: Pfizer's operating cash flow increased by 12.0% year-over-year, from $2.34B to $2.62B.
What is the long-term trend for Pfizer's operating cash flow?: Over 3 years (2021 to 2025), Pfizer's operating cash flow has grown at a -27.8% compound annual growth rate (CAGR), from $32.58B to $12.29B.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.